Document:

PRODUCT MARKETING AGREEMENT

THIS AGREEMENT is made this 23rd day of November, 2010 by and between China Ventures Inc, (CV) a Nevada corporation with offices located at Sichuan, Chengdu 641001 Ren Min Nan Lu 4 duan 27 hao, Shang Ding Guoji 2 dong 1 danyuan 1015 (Hereinafter “CV” or “MiUSA”), and EnviraTrends, Inc., a Wyoming corporation with offices located at 1900 Main St., Suite 312, Sarasota, FL  34236 (hereinafter “Product Company”).

 

WITNESSETH:

WHEREAS, PRODUCT COMPANY desires to engage CV to assist in introducing its products into the China market;

WHEREAS, CV has established a methodology to introduce the products of US companies into the China market through its Made in the USA Project (MiUSA); and

WHEREAS, PRODUCT COMPANY is willing and able to provide Product(s) to the MiUSA Project of CV in order to test the China market in accordance with the terms and conditions set forth herein.

NOW, THEREFORE, in consideration of the mutual promises and covenants herein contained, the parties agree as follows:

	
  

	
1.

	
Duties of PRODUCT COMPANY.

	
  

	
i.

	
PRODUCT COMPANY will deliver to CV’s warehouse in Chengdu China the Product(s) set forth in Exhibit I in the quantities so specified.  The Product(s) will be packaged for immediate retail sample and sale. By mutual agreement, the Products may be manufactured in China and delivered to CV’s warehouse in Chengdu.

	
  

	
ii.

	
PRODUCT COMPANY will pay the transportation and VAT and import duties for the Product(s) necessary to deliver the Product to the CV’s warehouse.

	
  

	
iii.

	
Product Company when requested by CV will supply the documents and information required by the SFDA necessary to register/license the Product(s) in China such as but not limited to the following:

	
  

	
§

	
Registered trademark proof

	
  

	
§

	
Product formulation (raw materials and auxiliary materials) and the sources of raw materials and auxiliary materials and use basis.

  

  

  

 

	
  

	
§

	
Functional ingredients and the inspection method.

	
  

	
§

	
Sketch of manufacturing technique and detailed specification and relevant research data.

	
  

	
§

	
Product quality standard and the preparation of instructions

	
  

	
§

	
Product packing material type, name, quality standards and selection basis

	
  

	
§

	
Product labeling specifications

	
  

	 

	
  

	
§

	
Producing country’s relevant agencies documentary evidence that the product manufacturer conforms to local relevant manufacturing practices.

	
  

	
§

	
Notarized production and sales for more than one year

	
  

	
§

	
The producing country or International Organizations’ relevant standards related to the product.

	
  

	
§

	
Sample of the product’s package, label, and instruction for the market of their producing country

	
  

	
2.

	
Duties of CV/MiUSA.

	 	
A. 

	
Basic Services

	
  

	
i.

	
MiUSA will translate Product documentation as necessary and label and assist through China Customs Clearance.  MiUSA will rely upon all information supplied by Product Company for the label translation but will assume all liability for the accuracy of the translated label.

	
  

	
ii.

	
MiUSA will establish the Product in at least one brick-and-mortar retail destination.  The MiUSA Project will collect the residual inventory and invoiced amount due for the Product Company.

	
  

	
iii.

	
MiUSA will develop a Pet memorial street Team necessary to promote the USA produced Product through a sample program in locations adjacent to the key outlets and during optimal foot-traffic timing periods.

	
  

	
iv.

	
MiUSA, through surveys, will deliver the findings to the Product Company enabling the Product Company to expand, augment, adjust or abandoned the market.

	
  

	
v.

	
MiUSA will introduce the Product to qualified distributors and sign a minimum of 5 (five) distributors for the Product distribution.

	
  

	
vi.

	
MiUSA will register/license the Product in China as a pet memorial product.  To acquire a registration/license is a minimum six months and maximum of eighteen months process. CV will not be responsible for the registration delay if the Product Company fails to provide the necessary documentation.

  

2

 

	
  

	
vii.

	
MiUSA will provide a private labeler to package and/or produce the Product domestically.  The Product Company is under no obligation to accept or use the private labeler.

	
  

	
B.

	
Additional Services – the following additional services are available on a negotiated basis.

	
  

	
viii.

	
MiUSA will offer to assist in developing national distribution for welcomed products on terms to be negotiated between all parties separate from this Agreement.

	
  

	
ix.

	
MiUSA will assist in developing and translating external marketing and promotional materials locally and nationally.  The MiUSA team is able to assist in China trade shows.

	
  

	
x.

	
MiUSA will translate promotional materials associated and provided with US manufactured products.

	
  

	
3.

	
Costs and Payment Terms

Cost of Services: $40,000 cash

Payment Terms:

1.      50% pre pay - $20,000 (does not cover the cost of the license estimated at $10,000, represents MiUSA’s risk)

2.      25% when order for 100 units of the product are placed stores are placed - $10,000 (verifiable);

3.      15% when distributor is signed - $6,000;

4.      10% when product is officially registered - $4,000

Payments are due upon execution of this Agreement.  MiUSA is only paid the last payment if all milestones set forth above are met.

If milestones 2, 3 and 4 are not met, Product Company is not liable for the amounts associated with such milestones, and MiUSA expressly waives any right to collect such amounts from Product Company.

	
  

	
4.

	
Term of Agreement.  The term of this Agreement is one (1) year and may be renewed for an additional term by mutual written agreement or until the registration/licensing of the Product is complete, whichever is later.

	
  

	 

	
  

	
5.

	
Confidentiality:  The parties agree not to disclose any proprietary information of a confidential nature ("Confidential Information") concerning their business dealings to anyone other than authorized employees and agents of the parties either during or subsequent to the term of this Agreement. Confidential Information includes, but is not limited to proprietary data relating to the business affairs and operations, whether in writing, orally or by demonstration, including methods, procedures, compositions, material trade secrets and any product manufactured, related or developed in whole or in part therefrom.

  

3

 

	
  

	
6.

	
Due Authorization:  The parties represent that the execution and delivery by the each party to this Agreement, the performance and the consummation by both parties to the transactions contemplated by this Agreement have been duly authorized by all requisite corporate action on the part of the each party.

	
  

	
7.

	
Miscellaneous

a.           Notices

i.  Any notice required to be given pursuant to this Agreement shall be in writing and mailed by certified or registered mail, return receipt requested, or delivered by a national overnight express service such as Federal Express, or by tele-fax communication with an acknowledgment by the recipient.

ii. Either party may change the address to which notice or payment is to be made by written notice to the other party under any provision of this Paragraph.

b.           Jurisdiction And Disputes

	
  

	
i.

	
All issues relating to this Agreement and their formation, performance and enforcement shall be governed by and construed in accordance with the substantive Laws of the State of Nevada of the United States of America, without giving effect to any choice of Law or conflict of Laws rules or provisions (whether of the State of Nevada or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Nevada.

	
  

	
ii.

	
All disputes hereunder shall be resolved in the applicable state or federal courts of Nevada.  The parties consent to the jurisdiction of such courts, agree to accept service of process by mail, and waive any jurisdictional or venue defenses otherwise available.

	 	
 c.

	
Agreement Binding On Successors

This Agreement shall be binding on and shall inure to the benefit of the parties hereto, and their heirs, administrators, successors, and assigns.

d.           Waiver

No waiver by either party of any default shall be deemed as a waiver of any prior or subsequent default of the same or other provisions of this Agreement.

 

  

4

 

e.           Severability

If any provision hereof is held invalid or unenforceable by a court of competent jurisdiction, such invalidity shall not affect the validity or operation of any other provision and such invalid provision shall be deemed to be severed from the Agreement.

f.           Assignability

This Agreement and the rights and obligations hereunder are non-assignable by operation of law or otherwise except by mutual consent of the parties.

g.           Integration

This Agreement constitutes the entire understanding of the parties, and revokes and supersedes all prior agreements between the parties and is intended as a final expression of their Agreement.  It shall not be modified or amended except in writing signed by the parties hereto and specifically referring to this Agreement.

h.           Counterparts.  This Agreement may be executed and delivered (including by facsimile transmission) in one or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement.

 

	
  

	
8. Intellectual Property.

	
  

	
MiUSA shall not acquire any right in any of the Product Company's or its affiliates' trademarks, trade dress, copyrights, promotional slogans, trade names, designs, labels, color combinations, product shapes, and other distinctive features in the Products, or the promotional goods, advertisements and promotional activities used during the term of this Agreement in conjunction with the advertising, promotion, distribution, and sale of the Products (collectively, the "Intellectual Property"). MiUSA is hereby granted the right during the term of this Agreement to use the Intellectual Property in re-labeling, advertising, promoting, distributing, and selling the Products in the China market; provided, however, that Product Company may require MiUSA to submit representative samples of any use of such Intellectual Property to Product Company for approval, which approval shall be deemed given if Product Company does not provide MiUSA with written notice of reasonable objection within ten (10) days of receipt of such samples. Any and all rights that may be acquired in the Intellectual Property by the use of the Intellectual Property by MiUSA will inure to the sole benefit of Product Company or its affiliates as the owner(s) of the Intellectual Property. MiUSA shall promptly notify Product Company of any and all infringements of the Intellectual Property pertaining to the Products that may come to MiUSA's attention.

 

  

5

 

IN WITNESS WHEREOF, the parties hereto, intending to be legally bound hereby, have each caused to be affixed hereto its hand and seal the day indicated.

	
China Ventures Inc.

	
EnviraTrends, Inc.

	  	  
	

	  
	
By: Steven M Allemang

	
By: Russell Haraburda

	
Title: Asian Director

	
Title: President

	  	  
	
Date:  2011/01/15

	
Date: 2011/01/15

 

  

6

 

EXHIBIT I - PRODUCT MARKETING AGREEMENT

  

Product(s):

Pet Memorials

Initial quantity delivered:

To be determined

 

  

7

 

Procedural Steps

	
  

	
1.

	
Identify Products

	
  

	
  i.

	
Determine quantity for samples

	
  

	
 ii.

	
If the product is a food item submit electronically ingredient label e-label@miusaproud.com   to determine capability for export

	
  

	
iii.

	
Determine individual licensing requirements

	
  

	
2.

	
Determine Fee

	
  

	
3.

	
Complete and Sign Agreement

	
  

	
4.

	
Send (via or Fax) Fee and Agreement to:

	 	
FAX 

	
(202) 318-7151

	
Fees: 

	
CITI Bank

Washington, DC

	
Account Name: 

	
China Ventures, Inc

Account Number 1549 0165

SWIFT: CITIUS33

Routing: 2540 70 116

	
  

	
5.

	
Manufacturer has Country of Origin certificate signed by local Chamber of Commerce office or Notarized by a local Notary

	
  

	
6.

	
Manufacturer completes Commercial Invoice

Made in USA Project

Xin Niu Yangzhi Youxian Zeren Gongsi

China, Sichuan Chengdu

Ren Min Nan Lu 4 duan 27 hao

Shang Ding Gou Ji 2-1-1015

Tel:    +86.28.8529.3170

 

	On the initial sample order Commercial Invoice please include the cost extension BUT in the TOTAL amount enter, SAMPLE 

   

	
  

	
7.

	
Manufacturer sends

	
  

	
a.

	
Samples

	
  

	
b.

	
Country of Origin Certificate

	
  

	
c.

	
Commercial Invoice

	
  

	
8.

	
Made In USA places products into the process.

 

  

8EXHIBIT 10.30.6

 

FORM OF RESTRICTED STOCK AGREEMENT

 

This RESTRICTED STOCK AGREEMENT (the “Agreement”) is made and entered into by and between Pharmathene, Inc. (the “Company”), and ________________ (“Grantee”), as of this ____ day of __________ 20__, pursuant to the terms and provisions set forth herein.

 

WHEREAS, Grantee is employed by the Company and, as a matter of separate inducement and agreement in connection with Grantee's employment, and not in lieu of any salary or other compensation for Grantee’s services, the Company desires to make an award to grantee under the Company’s 2007 Long-Term Incentive Compensation Plan (the “Plan”) and to enter into this Agreement with Grantee; and

 

WHEREAS, the Company considers it to be in its best interests to provide Grantee an inducement to acquire an ownership interest in the Company and thereby an additional incentive to advance the interests of the Company.

 

NOW, THEREFORE, intending to be legally bound, in consideration of the mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

Section 1.  Grant.  On the effective date hereof, the Company hereby grants to Grantee _________________ shares of the Company’s Common Stock, $0.0001 par value (the “Restricted Stock”), at no cost to the Grantee.

 

The Restricted Stock is subject to the terms and provisions of the Plan, and to the following provisions of this Agreement:

 

Section 2.  Vesting.  The Restricted Stock will vest as follows:  ______________________.

 

Section 3.  Issuance of Shares.  Upon vesting and Grantee’s compliance with Section 7 hereof, the Company shall cause certificates for the Restricted Stock to be issued to Grantee (or Grantee’s designee).

 

Section 4.  Transferability.  The Restricted Stock may not be transferred or encumbered in any manner prior to vesting except by will or the laws of descent and distribution. The transferee of any Restricted Stock will be subject to all restrictions, terms, and conditions applicable to the Restricted Stock, including such further agreements and restrictions as may be required as a condition of the grant or issuance of shares.

 

Section 5.  Shareholder Rights and Restrictions.  Except with regard to the disposition or encumbrance of Restricted Stock, the Grantee will generally have all rights of a shareholder with respect to the Restricted Stock from the Grant Date, including, without limitation, the right to receive dividends with respect to such Restricted Stock and the right to vote such Restricted Stock, subject to any restrictions in this Agreement.

 

Section 6.  Dividends.  All dividends payable on the Restricted Stock (whether or not vested) will be payable in cash.

  

  

 

Section 7.  Taxes.  The Grantee hereby agrees to pay to the Company any federal, state, or local taxes of any kind required by law to be withheld and remitted by the Company with respect to the Restricted Stock. The Company, in its sole discretion, may permit the Grantee may satisfy such tax obligation, in whole or in part, by (i) electing to have the Company withhold a portion of the Restricted Stock otherwise to be delivered upon vesting of the Restricted Stock with a Fair Market Value equal to the amount of such taxes, or (ii) delivering to the Company other shares of common stock of the Company with a Fair Market Value equal to the amount of such taxes. The election, if any, must be made on or before the date that the amount of tax to be withheld is determined. If the Grantee does not make such payment to the Company, the Company shall have the right to withhold from any payment of any kind otherwise due to the Grantee from the Company, any federal, state or local taxes of any kind required by law to be withheld with respect to the award or vesting of the Restricted Stock.

 

Section 8.  Securities Law Compliance.

 

(a) The Grantee agrees that the Company may impose such restrictions on the Restricted Stock as are deemed advisable by the Company, including, without limitation, restrictions relating to listing or trading requirements. The Grantee further agrees that certificates representing the Restricted Stock may bear such legends and statements as the Company shall deem appropriate or advisable to assure, among other things, compliance with applicable securities laws, rules, and regulations.

 

(b) The Grantee agrees that any Restricted Stock which the Grantee may acquire by virtue of this Agreement may not be transferred, sold, assigned, pledged, hypothecated or otherwise disposed of by the Grantee unless (i) a registration statement or post-effective amendment to a registration statement under the Securities Act of 1933, as amended, with respect to such Restricted Stock has become effective so as to permit the sale or other disposition of such Restricted Stock by the Grantee, or (ii) there is presented to the Company an opinion of counsel satisfactory to the Company to the effect that the sale or other proposed disposition of such Restricted Stock by the Grantee may lawfully be made otherwise than pursuant to an effective registration statement or post-effective amendment to a registration statement relating to such Restricted Stock under the Securities Act of 1933, as amended.

 

Section 9.  Rights of the Grantee.  The granting of the Restricted Stock shall in and of itself not confer any right of the Grantee to continue in the employ of the Company, any subsidiary or affiliate and shall not interfere in any way with the right of the Company, any subsidiary or affiliate to terminate the Grantee's employment at any time, subject to the terms of any employment agreement between the Company and the Grantee.

 

Section 10.  Governing Law.  This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, except to the extent otherwise governed by federal law.

 

Section 11.  Right to Withhold Amounts Owed to the Company.  The Company shall have the right to condition the vesting of any shares of Restricted Stock on the Grantee’s payment of all amounts then due and owing to the Company or any subsidiary or affiliate.

 

IN WITNESS WHEREOF, the parties have subscribed their names hereto.

 

	
Attest:

	 	
PHARMATHENE, INC.

	  	 	  	  
	
By:

	  	 	
By:

	  
	
Name:

	  	 	  	
[Name]

 

GRANT DATE:

  

-2-

 

 

ACCEPTANCE OF AGREEMENT

 

The Grantee hereby:

 

(a) Acknowledges that he has received a copy of the Company’s most recent Annual Report and other communications routinely distributed to the Company’s shareholders;

 

(b) Accepts this Agreement and the Restricted Stock granted to him under this Agreement subject to all provisions of this Agreement;

 

(c) Represents and warrants to the Company that she/he is acquiring the Restricted Stock for her/his own account, for investment, and not with a view to or any present intention of selling or distributing the Restricted Stock either now or at any specific or determinable future time or period or upon the occurrence or nonoccurrence of any predetermined or reasonably foreseeable event; and

 

(d) Agrees that no transfer of the Restricted Stock will be made unless the Restricted Stock have been duly registered under all applicable federal and state securities laws pursuant to a then effective registration which contemplates the proposed transfer or unless the Company has received the written opinion of, or satisfactory to, its legal counsel that the proposed transfer is exempt from such registration.

 

Grantee’s Signature:

 

	  	  	
Date: ____________, 20__

 

	
(Print Name):  

	  

  

-3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}]]